All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 30, 2023
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for Feb. 18, 2020

Feb. 18, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Amarillo, Aptorum, Cipla, CNS Pharma, Codagenix, Cytodyn, Daewoong, Dr. Reddy’s, J&J, Jianjin University Haihe Hospital, Luye, M8 Pharma, Monash University, Recce, Synergy, Vir, Wockhardt, WPD Pharma, Xiamen Weiyang.
Read More

Regulatory front for Feb. 18, 2020

Feb. 18, 2020
No Comments
The latest global regulatory news, changes and updates affecting biopharma, including: Sanofi, Sandoz.
Read More
Coronavirus and DNA
American Association for the Advancement of Science

Researchers trace COVID-19’s family tree to battle outbreak and ‘infodemic’

Feb. 14, 2020
By Nuala Moran
No Comments
SEATTLE – Tracing the family tree of COVID-19 through its evolving DNA sequence makes it possible to disprove many false claims circulating on social media about the novel coronavirus, and, in particular, that it was generated in a covert biological weapons program. “From everything I’ve looked at, there is zero evidence for genetic engineering; it looks like normal evolution,” said Trevor Bedford, a computational biologist at Fred Hutchinson Cancer Research Center, who has been using genomes sequences taken from patient samples to track the spread of the virus since Jan. 11.
Read More
DNA illustration

Researchers develop diagnostic system that detects up to 40 infectious respiratory pathogens in one test

Feb. 14, 2020
By Elise Mak
No Comments
BEIJING – Researchers from The Hong Kong Polytechnic University (PolyU) have developed a diagnostic system that they claim is the world’s most comprehensive as it can identify 30 to 40 pathogens in one single test within an hour.
Read More

Other news to note for Feb. 14, 2020

Feb. 14, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Assertio, Canagen, Collegium, Exicure, Genix, Melinta, Morphic, Recce, Vaxil.
Read More
U.S. health compass

Azar: Grassley-Wyden bill leaves ‘plenty of room’ for profits, innovation

Feb. 13, 2020
By Mark McCarty
No Comments
Health and Human Services (HHS) Secretary Alex Azar was peppered with questions about the Trump administration’s budget proposal for fiscal 2021 during a Feb. 13 Senate hearing. However, another theme that resonated during the hearing was Senate legislation addressing drug prices. Azar addressed the issue of price caps, while noting that the bill “leaves plenty of room” for both ample profit margins and innovation in drug development.
Read More
Flag of China and masks

Argentina ramps up production of face masks as Chinese demand surges

Feb. 13, 2020
By Sergio Held
No Comments
BOGOTA, Colombia – Medical supply manufacturers in Argentina have seen a surge in demand for their products from China, which is reaching out globally for the goods it needs to deal with the outbreak of COVID-19.
Read More

Clover produces subunit vaccine candidate S-Trimer for coronavirus

Feb. 13, 2020
By Elise Mak
No Comments
BEIJING – Chinese biotech companies are focusing on fighting the novel coronavirus, now named as COVID-19 by the WHO, after the country’s government called for all possible assistance. With its Trimer-Tag technology, Chengdu-based Sichuan Clover Biopharmaceuticals Inc. is among the first to reveal production of a vaccine candidate against COVID-19.
Read More

Other news to note for Feb. 13, 2020

Feb. 13, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Afaxys, Amarillo, Amorchem, Calidi, Codagenix, CSL Behring, Dendreon, Evgen, Forma, Homology, Human Microbiology Institute, Promedior, Riptide, Roche, Tetra Bio-Pharma, Therapeuticsmd, Xiamen Weiyang.
Read More
Coronavirus viral membrane

Australia ramps up efforts to fight coronavirus with genetic sequence in hand

Feb. 12, 2020
By Tamra Sami
No Comments
PERTH, Australia – As of Feb. 12, Australia’s Department of Health confirmed 15 cases of novel coronavirus in Australia (five in Queensland, four in New South Wales, four in Victoria and two in South Australia). Of the confirmed 15 cases, five people have recovered and the others are in stable condition.
Read More
Previous 1 2 … 478 479 480 481 482 483 484 485 486 … 503 504 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 29, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for March 29, 2023.
  • Kirill Pevzner and Eran Seger - Protai

    AI drug discovery startup Protai raises $12M in seed funding

    BioWorld
    Artificial intelligence (AI)-powered drug discovery startup Protai Bio Ltd. raised $12 million in additional seed funding, bringing the total amount to $20...
  • Elderly woman holding illustration of brain with missing puzzle piece

    ‘Not a slowdown, a reversal’: Truebinding tackling Alzheimer’s via galectin-3

    BioWorld
    In Alzheimer’s, the amyloid beta hypothesis has proved most persistent in terms of drug development efforts to date, but aggregation of other pathogenic factors –...
  • Gold wireframe handshake

    A $4 million handshake with investor helps propel First Wave Biopharma’s CF offering

    BioWorld
    An investor has seen promise in First Wave Biopharma Inc.’s targeted, systemic gastrointestinal disease biotherapeutics, offering $4 million in a private...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing